Eptinezumab

ATC N02CD05 · 9 markets · 13 records

Eptinezumab 9 markets · 13 records Forms

AU 3 records · 3 strengths

  • 100 mg/1 mLinjectionVyepti also in GB
  • 100 mg/mLinjectionVYEPTI eptinezumab 100 mg/mL concentrated injection single use vial also in SG unknown

Records without a stated strength · 1 Vyepti

CA 2 records · 2 strengths

ES 2 records · 1 strengths

US 1 records · 1 strengths

GB 1 records · 1 strengths

  • 100 mg/1 mLinjectionVyepti 100mg/1ml concentrate for solution for infusion vials also in AU

SG 1 records · 1 strengths

  • 100 mg/mLinjectionVYEPTI CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/ML also in AU

MX 1 records · 1 strengths

    Records without a stated strength · 1 Vyepti

    HK 1 records · 1 strengths

      Records without a stated strength · 1 VYEPTI CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/1ML

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 Vyepti

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.